Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current Assets:    
Cash and cash equivalents $ 6,062,173 $ 4,401,114
Prepaid research and development 9,931 233,035
Prepaid expenses and other current assets 389,501 501,689
Total Current Assets 6,461,605 5,135,838
Fixed Assets, net 58,149
Intangible assets, net 5,041 5,606
Acquired in-process research and development 455,000
Right-to-use Asset 246,209
Goodwill 248,971
Advance to seller 350,000
Total Assets 7,474,975 5,491,444
Current Liabilities:    
Accounts payable 286,192 648,739
Accrued expenses 2,376,930 856,639
Lease liability, current 49,585
Other current liabilities 9,683
Total Current Liabilities 2,722,390 1,505,378
Long-term Liabilities:    
Contingent liabilities 1,014,000
Lease liability, non-current 207,375
Deferred tax liability 23,399
Total Liabilities 3,967,164 1,505,378
Commitments and contingencies
Stockholders’ Equity    
Preferred Stock, 5,000,000 shares authorized with a par value of $0.001 per share, 0 shares outstanding at December 31, 2021 and 2020
Common Stock, 50,000,000 shares authorized with a par value of $0.001 per share, 20,946,712 and 14,393,100 shares issued and outstanding at December 31, 2021 and 2020, respectively 20,947 14,393
Additional paid in capital 54,429,979 35,491,462
Accumulated deficit (50,943,115) (31,519,789)
Total Stockholders’ Equity 3,507,811 3,986,066
Total Liabilities and Stockholders’ Equity $ 7,474,975 $ 5,491,444